Q&A with Medicus: Getting to know the new(ish) kid on the pension block'One of the really cool things about Medicus is the plug-in of what we call longevity risk,' explains Simone Reitzes, managing director of the Medicus pension plan launched earlier this year by Scotiabank. Anxiety vs. stress: The right definition will lead to better mental healthcareIdentifying individuals with high stress levels is challenging since there is a lack of consensus or guideline on the best screening method to be used in family practice. The world’s first gene therapy for sickle cell disease has been approved in Britain Both sickle cell disease and thalassemia are caused by mistakes in the genes that carry hemoglobin, the protein in red blood cells that carry oxygen. Dr. Alika Lafontaine hosts new podcast The Healthcare Divide takes a hard look at healthcare inequities relating to race. First vaccine for chikungunya gets fast-track approval in the U.S. But studies continue to determine risks of adverse reactions. Cold air keeps croup at bay, and now a study proves it Canadian docs often suggest parents take kids out into the cold. Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds The findings could shift perceptions that the new class of obesity drugs are cosmetic treatments and put pressure on health insurers to cover them. Much ado in the world of Lyme vaccine development Three different approaches in the pipeline. Face mask use reduces SARS-CoV-2 transmission in community settings Use of face masks in the community will be an important component of an effective response to any future respiratory threats. Polypharmacy rising among seniors with heart failure Quebecers aged 65 and over with heart failure are taking more and more different pharmacological treatments, according to a new study First Previous 73 74 75 76 77 Next Last
